Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy

Keyphrases

• Ovarian Cancer 100%
• Targeted Therapy 100%
• Nanodrug 100%
• New Frontiers 100%
• Conventional Therapy 66%
• Neutrophil Extracellular Traps 66%
• Metastasis 33%
• Immune Evasion 33%
• Novel Therapeutics 33%
• Tumor-promoting 33%
• Tumor Microenvironment 33%
• Gynecological Cancer 33%
• Doxorubicin 33%
• Acidic Tumor Microenvironment 33%
• Pharmacologic 33%
• Nanomedicine 33%
• Disease Progression 33%
• Cancer Mortality 33%
• Platelet-derived Growth factor-BB (PDGF-BB) 33%
• Tumor Growth 33%
• Systemic Toxicity 33%
• Platelet Activation 33%
• Hemostasis 33%
• TGF-1 33%
• Platelets 33%
• Advanced Ovarian Cancer 33%
• Antiplatelet Agents 33%
• Ovarian Cancer Screening 33%
• Late-stage Diagnosis 33%
• Co-load 33%
• Epithelial-to-mesenchymal Transition 33%
• Thromboembolic Complications 33%
• Tumor Immunology 33%
• Immune Resistance 33%
• Activated Platelets 33%
• Multi-target Approach 33%
• Activated Leukocytes 33%
• Systemic Bleeding 33%
• P-selectin 33%
• Mechanistic Role 33%
• Immunosuppressive Environment 33%
• Thromboinflammation 33%
• Ovarian Cancer Progression 33%
• NETosis 33%
• PH-sensitive Nanoparticles 33%
• Immune Polarization 33%
• Biological Heterogeneity 33%
• Cytotoxic Efficacy 33%

Immunology and Microbiology

• Platelet 100%
• Thrombocyte Activation 66%
• Neutrophil Extracellular Traps 66%
• Immunosuppressive Drug 33%
• Immune Evasion 33%
• Immunocompetent Cell 33%
• Cancer Mortality 33%
• Leukocyte 33%
• Epithelial Mesenchymal Transition 33%
• Hemostasis 33%
• Tumor Immunology 33%
• NETosis 33%
• P-Selectin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Ovary Cancer 100%
• Neoplasm 40%
• Tumor Microenvironment 40%
• Nanoparticle 20%
• Doxorubicin 20%
• Preclinical Study 20%
• Clinical Study 20%
• Female Genital Tract Cancer 20%
• Nanomedicine 20%
• Tumor Growth 20%
• Disease Exacerbation 20%
• Cancer Mortality 20%
• Blood Stasis 20%
• Immunosuppressive Agent 20%
• Antithrombocytic Agent 20%
• P-Selectin 20%